- Report
- March 2025
- 175 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- November 2023
- 126 Pages
Global
From €6730EUR$7,500USD£5,792GBP
- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
Meclizine is a medication used to treat motion sickness and vertigo. It is classified as an antihistamine and anticholinergic, and is commonly used as an over-the-counter drug for the treatment of nausea, vomiting, and dizziness associated with motion sickness. It is also used to treat vertigo, a condition in which a person experiences a spinning sensation. Meclizine is a popular choice for treating gastrointestinal issues, as it is known to reduce nausea and vomiting. It is also used to treat vertigo, a condition in which a person experiences a spinning sensation.
Meclizine is available in both prescription and over-the-counter forms. It is typically taken orally, either as a tablet or capsule, or as a liquid suspension. It is also available as a topical cream or ointment.
The Meclizine market is a part of the larger Gastrointestinal Drugs market. It is a competitive market, with many companies offering different formulations of the drug. Companies such as Pfizer, GlaxoSmithKline, and Merck & Co. are some of the major players in the market. Other companies such as Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals also offer Meclizine products. Show Less Read more